Alsayed A - Search Results

1

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience.

Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T. Elkum N, et al. Among authors: alsayed a. BMC Cancer. 2007 Dec 5;7:222. doi: 10.1186/1471-2407-7-222. BMC Cancer. 2007. PMID: 18053234 Free PMC article.

2

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer.

Al-Tweigeri TA, Ajarim DS, Alsayed AA, Rahal MM, Alshabanah MO, Tulbah AM, Al-Malik OA, Fatani DM, El-Husseiny GA, Elkum NB, Ezzat AA. Al-Tweigeri TA, et al. Among authors: alsayed aa. Med Oncol. 2010 Sep;27(3):571-7. doi: 10.1007/s12032-009-9251-7. Epub 2009 Jun 13. Med Oncol. 2010. PMID: 19526202 Clinical Trial.

3

Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?

Suleman K, Almalik O, Haque E, Mushtaq A, Badran A, Alsayed A, Ajarim D, Al-Tweigeri T, Jastaniyah N, Elhassan T, Alkhayal W. Suleman K, et al. Among authors: alsayed a. Oncology. 2020;98(3):168-173. doi: 10.1159/000504964. Epub 2020 Jan 9. Oncology. 2020. PMID: 31918425

4

A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer.

A L-Tweigeri T, AlSayed A, Alawadi S, Ibrahim M, Ashour W, Jaafar H, Abulkhair O, A L-Abdulkarim H, Khalid H, Ajarim D; Gulf Oncology Research Group (GORG-001). A L-Tweigeri T, et al. Among authors: alsayed a, a l abdulkarim h. Cancer Chemother Pharmacol. 2016 Jan;77(1):147-53. doi: 10.1007/s00280-015-2906-5. Epub 2015 Nov 12. Cancer Chemother Pharmacol. 2016. PMID: 26563257 Clinical Trial.

5

Reply to "Letter to the Editor Concerning the Article-Impact of Surgery on Survival in Stage IV Breast Cancer".

Al Johani B, Al Malik O, Anwar E, Tulbah A, Alshabanah M, AlSayed A, Ajarim D, Al-Tweigeri T. Al Johani B, et al. Among authors: alsayed a. Breast J. 2017 Jan;23(1):119. doi: 10.1111/tbj.12701. Epub 2016 Oct 31. Breast J. 2017. PMID: 27797125 No abstract available.

6

Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population.

Osmani AH, Tulbah AM, AlSayed A, AlShanqeeti A, Al-Twegieri T, Ajarim DS, Suleman K. Osmani AH, et al. Among authors: alsayed a. Am J Case Rep. 2021 Feb 5;22:e928012. doi: 10.12659/AJCR.928012. Am J Case Rep. 2021. PMID: 33544698 Free PMC article.

7

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer.

Al-Tweigeri T, Elshenawy M, Badran A, Omar A, Suleman K, Al Malik O, Anwar I, Jastaniya N, Tulbah A, Al Shabanah M, Ajarim D, Al Sayed A. Al-Tweigeri T, et al. J Oncol. 2021 Feb 12;2021:6639763. doi: 10.1155/2021/6639763. eCollection 2021. J Oncol. 2021. PMID: 33628241 Free PMC article.

8

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer.

Ghebeh H, Al-Sayed A, Eiada R, Cabangon L, Ajarim D, Suleman K, Tulbah A, Al-Tweigeri T. Ghebeh H, et al. Sci Rep. 2021 Sep 27;11(1):19154. doi: 10.1038/s41598-021-98113-6. Sci Rep. 2021. PMID: 34580336 Free PMC article. Clinical Trial.

9

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer.

Alshamsan B, Alshibany A, Elshenawy MA, Badran A, Elhassan T, Ajarim D, Alsayed A, Suleman K, Al-Tweigeri T. Alshamsan B, et al. Among authors: alsayed a. Cancer Manag Res. 2021 Dec 29;13:9411-9420. doi: 10.2147/CMAR.S343549. eCollection 2021. Cancer Manag Res. 2021. PMID: 35002318 Free PMC article.

10

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.

Alshamsan B, Suleman K, Agha N, Abdelgawad MI, Alzahrani MJ, Elhassan T, Al-Tweigeri T, Ajarim D, Alsayed A. Alshamsan B, et al. Among authors: alsayed a. Int J Womens Health. 2022 Mar 12;14:373-384. doi: 10.2147/IJWH.S343558. eCollection 2022. Int J Womens Health. 2022. PMID: 35309953 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters